clarithromycin has been researched along with HIV in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Armstrong, WS; Eaton, ME; Kelley, CF | 1 |
Kobayashi, C; Sakai, T; Shinohara, M | 1 |
Brown, BA; Griffith, DE; Wallace, RJ | 1 |
3 other study(ies) available for clarithromycin and HIV
Article | Year |
---|---|
Disseminated Mycobacterium haemophilum infection.
Topics: Acquired Immunodeficiency Syndrome; Anti-Bacterial Agents; Anti-HIV Agents; Cellulitis; Clarithromycin; HIV; Humans; Immunocompromised Host; Male; Middle Aged; Mycobacterium haemophilum; Mycobacterium Infections; Ofloxacin; Rifabutin | 2011 |
Mycobacterium peregrinum infection in a patient with AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; beta-Lactams; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; HIV; Humans; Imipenem; Lactams; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; RNA, Viral | 2005 |
Varying dosages of rifabutin affect white blood cell and platelet counts in human immunodeficiency virus--negative patients who are receiving multidrug regimens for pulmonary Mycobacterium avium complex disease.
Topics: Azithromycin; Clarithromycin; Dose-Response Relationship, Drug; Drug Therapy, Combination; HIV; Humans; Leukocyte Count; Lung Diseases; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Platelet Count; Rifabutin | 1996 |